Table 3.
IFN-γ | IL-10 | IL-12p70 | IL-13 | IL-1β | IL-2 | IL-6 | IL-8 | TNF-α | IL-17A | IL-5 | IL-7 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Saliva | ||||||||||||
Mean (SD) (pg/mL) | 5.58 (12.57) | 0.76 (0.45) | 0.51 (0.30) | 6.69 (3.32) | 108.49 (117.82) | 0.80 (0.57) | 4.38 (4.44) | 687.64 (650.03) | 3.16 (2.39) | 2.27 (11.61) | 0.61 (3.11) | 15.05 (8.10) |
Min-Max (pg/mL) | 0.94–80.29 | 0.18–2.16 | 0.15–1.74 | 2.05–16.9 | 6.55–544.21 | 0.11–2.59 | 1.03–25.21 | 141.74–3373.5 | 0.4–9.99 | 0.06–80.08 | 0.02–21.59 | 1.66–31.35 |
Range |
80.29 |
1.98 |
1.59 |
14.85 |
537.66 |
2.48 |
24.18 |
3231.76 |
9.95 |
80.02 |
21.57 |
29.69 |
Serum | ||||||||||||
Mean (SD) (pg/mL) | 4.37 (3.46) | 0.42 (0.21) | 0.54 (0.23) | 4.52 (1.67) | 0.26 (0.37) | 0.71 (0.31) | 1.27 (0.79) | 5.09 (4.64) | 1.01 (0.37) | 0.89 (0.88) | 0.42 (0.24) | 6.36 (6.98) |
Min-Max (pg/mL) | 1.92–17.24 | 0.09–0.85 | 0.2–1 | 0.7–7.27 | 0.01–1.32 | 0.08–1.24 | 0.47–3.48 | 2.04–23.51 | 0.25–1.9 | 0.24–4.04 | 0.07–0.93 | 0.05–32.44 |
Range | 15.32 | 0.76 | 0.8 | 6.57 | 1.31 | 1.16 | 3.11 | 21.47 | 1.65 | 3.8 | 0.86 | 32.39 |
Fold Increase in Saliva | 1.27 | 1.80 | 0.93 | 1.48 | 408.3 | 1.12 | 3.43 | 135.15 | 3.12 | 2.54 | 1.47 | 2.37 |